The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible for autosomal dominant polycystic kidney disease (ADPKD), the most common ...
Pharmaceutical companies raised prices for most medicines. Federal government policy changes then drove the reductions.
The final, formatted version of the article will be published soon. Background: Computed tomography angiography (CTA), utilizing iodinated contrast agents, is a first-line diagnostic tool for ...
In this retrospective study, researchers explored whether reducing osimertinib dose in EGFR-mutated metastatic NSCLC patients who experienced adverse events would worsen survival.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results